Brainstorm Cell Therapeutics Net Income
| BCLI Stock | USD 0.54 0.04 6.86% |
As of the 9th of February, Brainstorm Cell shows the mean deviation of 3.59, and Risk Adjusted Performance of (0.01). Brainstorm Cell Ther technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Brainstorm Cell Total Revenue |
|
| Last Reported | Projected for Next Year | ||
| Net Loss | -10.5 M | -11 M | |
| Net Loss | -10.5 M | -11 M | |
| Net Loss | -21.8 M | -20.8 M | |
| Net Income Per Share | 1.97 | 2.07 | |
| Net Income Per E B T | 0.90 | 0.72 |
Brainstorm | Net Income | Build AI portfolio with Brainstorm Stock |
The Net Income trend for Brainstorm Cell Therapeutics offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Brainstorm Cell is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Brainstorm Cell's Net Income Growth Pattern
Below is the plot of the Net Income of Brainstorm Cell Therapeutics over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Brainstorm Cell Ther financial statement analysis. It represents the amount of money remaining after all of Brainstorm Cell Therapeutics operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Brainstorm Cell's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Brainstorm Cell's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (11.62 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Brainstorm Net Income Regression Statistics
| Arithmetic Mean | (8,309,772) | |
| Geometric Mean | 7,275,070 | |
| Coefficient Of Variation | (154.97) | |
| Mean Deviation | 10,076,332 | |
| Median | (4,982,000) | |
| Standard Deviation | 12,877,726 | |
| Sample Variance | 165.8T | |
| Range | 43.4M | |
| R-Value | 0.04 | |
| Mean Square Error | 176.6T | |
| R-Squared | 0 | |
| Significance | 0.88 | |
| Slope | 97,471 | |
| Total Sum of Squares | 2653.4T |
Brainstorm Net Income History
Other Fundumenentals of Brainstorm Cell Ther
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Brainstorm Cell Net Income component correlations
Brainstorm Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Brainstorm Cell is extremely important. It helps to project a fair market value of Brainstorm Stock properly, considering its historical fundamentals such as Net Income. Since Brainstorm Cell's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Brainstorm Cell's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Brainstorm Cell's interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Biotechnology market expansion? Will Brainstorm introduce new products? Factors like these will boost the valuation of Brainstorm Cell. Projected growth potential of Brainstorm fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Brainstorm Cell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Brainstorm Cell Ther is measured differently than its book value, which is the value of Brainstorm that is recorded on the company's balance sheet. Investors also form their own opinion of Brainstorm Cell's value that differs from its market value or its book value, called intrinsic value, which is Brainstorm Cell's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Brainstorm Cell's market value can be influenced by many factors that don't directly affect Brainstorm Cell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Brainstorm Cell's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Brainstorm Cell should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Brainstorm Cell's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Brainstorm Cell 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Brainstorm Cell's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Brainstorm Cell.
| 11/11/2025 |
| 02/09/2026 |
If you would invest 0.00 in Brainstorm Cell on November 11, 2025 and sell it all today you would earn a total of 0.00 from holding Brainstorm Cell Therapeutics or generate 0.0% return on investment in Brainstorm Cell over 90 days. Brainstorm Cell is related to or competes with Neurosense Therapeutics, Matinas BioPharma, Adial Pharmaceuticals, Cardio Diagnostics, HCW Biologics, Impact BioMedical, and Acurx Pharmaceuticals. Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologo... More
Brainstorm Cell Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Brainstorm Cell's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Brainstorm Cell Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 24.01 | |||
| Value At Risk | (6.67) | |||
| Potential Upside | 9.09 |
Brainstorm Cell Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Brainstorm Cell's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Brainstorm Cell's standard deviation. In reality, there are many statistical measures that can use Brainstorm Cell historical prices to predict the future Brainstorm Cell's volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.16) | |||
| Total Risk Alpha | (0.62) | |||
| Treynor Ratio | (0.47) |
Brainstorm Cell February 9, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.46) | |||
| Mean Deviation | 3.59 | |||
| Coefficient Of Variation | (3,835) | |||
| Standard Deviation | 4.85 | |||
| Variance | 23.5 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.16) | |||
| Total Risk Alpha | (0.62) | |||
| Treynor Ratio | (0.47) | |||
| Maximum Drawdown | 24.01 | |||
| Value At Risk | (6.67) | |||
| Potential Upside | 9.09 | |||
| Skewness | 0.5269 | |||
| Kurtosis | 0.5095 |
Brainstorm Cell Ther Backtested Returns
Brainstorm Cell Ther secures Sharpe Ratio (or Efficiency) of -0.0181, which signifies that the company had a -0.0181 % return per unit of standard deviation over the last 3 months. Brainstorm Cell Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Brainstorm Cell's mean deviation of 3.59, and Risk Adjusted Performance of (0.01) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.29, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Brainstorm Cell's returns are expected to increase less than the market. However, during the bear market, the loss of holding Brainstorm Cell is expected to be smaller as well. At this point, Brainstorm Cell Ther has a negative expected return of -0.0894%. Please make sure to confirm Brainstorm Cell's standard deviation, kurtosis, period momentum indicator, as well as the relationship between the maximum drawdown and day median price , to decide if Brainstorm Cell Ther performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.07 |
Very weak reverse predictability
Brainstorm Cell Therapeutics has very weak reverse predictability. Overlapping area represents the amount of predictability between Brainstorm Cell time series from 11th of November 2025 to 26th of December 2025 and 26th of December 2025 to 9th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Brainstorm Cell Ther price movement. The serial correlation of -0.07 indicates that barely 7.0% of current Brainstorm Cell price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.07 | |
| Spearman Rank Test | -0.1 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Brainstorm Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Brainstorm Cell Therapeutics reported net income of (11.62 Million). This is 103.41% lower than that of the Biotechnology sector and 116.59% lower than that of the Health Care industry. The net income for all United States stocks is 102.04% higher than that of the company.
Brainstorm Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Brainstorm Cell's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Brainstorm Cell could also be used in its relative valuation, which is a method of valuing Brainstorm Cell by comparing valuation metrics of similar companies.Brainstorm Cell is currently under evaluation in net income category among its peers.
Brainstorm Cell Institutional Holders
Institutional Holdings refers to the ownership stake in Brainstorm Cell that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Brainstorm Cell's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Brainstorm Cell's value.| Shares | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 5.8 K | Harbour Investments, Inc. | 2025-06-30 | 3.6 K | Advisor Group Holdings, Inc. | 2025-06-30 | 1.8 K | Wells Fargo & Co | 2025-06-30 | 1.3 K | Citigroup Inc | 2025-06-30 | 663 | Activest Wealth Management | 2025-06-30 | 334 | Bangor Savings Bank | 2025-06-30 | 266 | Sbi Securities Co Ltd | 2025-06-30 | 218 | Jones Financial Companies Lllp | 2025-06-30 | 216 | Caldwell Sutter Capital Inc | 2025-06-30 | 157 K | Geode Capital Management, Llc | 2025-06-30 | 54.6 K |
Brainstorm Fundamentals
| Return On Equity | -11.22 | ||||
| Return On Asset | -4.0 | ||||
| Current Valuation | 6.79 M | ||||
| Shares Outstanding | 11.03 M | ||||
| Shares Owned By Insiders | 9.36 % | ||||
| Shares Owned By Institutions | 0.02 % | ||||
| Number Of Shares Shorted | 604.46 K | ||||
| Price To Earning | (16.00) X | ||||
| Price To Book | 65.82 X | ||||
| Revenue | 849 K | ||||
| EBITDA | (11.31 M) | ||||
| Net Income | (11.62 M) | ||||
| Cash And Equivalents | 12.24 M | ||||
| Cash Per Share | 0.34 X | ||||
| Total Debt | 720 K | ||||
| Debt To Equity | 0.60 % | ||||
| Current Ratio | 1.63 X | ||||
| Book Value Per Share | (0.70) X | ||||
| Cash Flow From Operations | (9.09 M) | ||||
| Short Ratio | 1.27 X | ||||
| Earnings Per Share | (1.42) X | ||||
| Target Price | 17.0 | ||||
| Number Of Employees | 23 | ||||
| Beta | 0.7 | ||||
| Market Capitalization | 6.18 M | ||||
| Total Asset | 1.83 M | ||||
| Retained Earnings | (226.64 M) | ||||
| Working Capital | (8.59 M) | ||||
| Current Asset | 16.79 M | ||||
| Current Liabilities | 2.95 M | ||||
| Net Asset | 1.83 M |
About Brainstorm Cell Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Brainstorm Cell Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Brainstorm Cell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Brainstorm Cell Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is there potential for Biotechnology market expansion? Will Brainstorm introduce new products? Factors like these will boost the valuation of Brainstorm Cell. Projected growth potential of Brainstorm fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Brainstorm Cell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Brainstorm Cell Ther is measured differently than its book value, which is the value of Brainstorm that is recorded on the company's balance sheet. Investors also form their own opinion of Brainstorm Cell's value that differs from its market value or its book value, called intrinsic value, which is Brainstorm Cell's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Brainstorm Cell's market value can be influenced by many factors that don't directly affect Brainstorm Cell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Brainstorm Cell's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Brainstorm Cell should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Brainstorm Cell's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.